Smiths Group has opened negotiations with American companies over a potential £6 billion deal to merge their operations in the field of health.
The engineering giant is in early stage discussions about combining it hand health with a string of companies, including the California medical intensive care.
The movement was initiated CEO Andy Reynolds Smith and spurred speculation that he became a target of activist investor. Smiths, which makes the device from security scanners at airports and medical equipment for the electrical connectors and hoses, saw its stock price to withstand pitching in recent months.
On Sunday evening a press-the Secretary Kuznetsov medical business confirmed that “it is in very early stage discussions about a possible combination of the medical Department with icu medical, Inc.”, adding that “Kuznetsov Council regularly considers all options for the group’s portfolio of businesses to maximize value for shareholders Smiths..
“There can be no assurance that the transaction will be concluded,” they added.
Its stock price is down turn in March, when half of the company for the year update showed the Headline pre-tax profit fell 12pc to £217m.
Since then, the stock price regained its balance, and now 16pc to $ 17.24 in comparison with the beginning of the year. Smiths medical, the healthcare arm of the company, has about 8,000 strong global workforce, and a strong presence in the United States. He recorded last year revenues of £951m, and an operating profit of £209m.